RxDoctor Payments DataLook up a doctor →

Xultophy 100/3.6: payments to doctors

Payments that named Xultophy 100/3.6 as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.4M
Providers
11,268
Transactions
32,829
Average per transaction
$43

The per-transaction average — $43 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,268 providers the average total is $125, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk$1,383,78298.0%
Novo Nordisk AS$25,6261.8%
Novo Nordisk Health Care AG$2,0000.1%
← All drugs & devices